Women with multiple sclerosis, particularly after menopause, experience a higher risk of relapse-independent worsening, ...

Broad rim lesions have been identified as a new biomarker for rapid multiple sclerosis progression, offering key insights ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

FRIDAY, Oct. 3, 2025 (HealthDay News) — Menopause does not increase symptoms and disability among women with multiple ...

Bruce Bebo, executive vice president of research at the National MS Society, says NMSS investments are helping advance MS ...

MS is a chronic autoimmune disorder that damages myelin, leading to symptoms such as vision issues, fatigue, coordination ...

Discover a new study showing that menopause does not accelerate disability in women with multiple sclerosis, offering ...

Multiple sclerosis (MS) could be "on the brink of a new class of treatment" after early trial results suggest two drugs may ...

With FDA-requested toxicology reports in hand, Quantum is preparing to seek clearance for stating the first trial of Lucid-MS ...